News Chart Galecto, Inc.

Equities

GLTO

US36322Q1076

Real-time Estimate Cboe BZX Other stock markets 14:24:12 2024-05-17 EDT			5-day change	1st Jan Change
0.623 ^USD	-1.11%		-9.43%	-14.49%

05-01	Galecto, Inc. Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab	CI
04-29	Galecto, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

b822fa62b1aac71d456cd5271e.2bCffqoNK6Lf3dViDn2z3dsAQ0gDqfFRNVhl6k5BCHg.753cEedGGciPj6c6fh7i5YlrNRtVn5I8GAEJrAgSRjWK-ftO_Ftp8bmTkA~d29ead499039766a5b3667782017b53a